companydata.dkNORDIC BIOTECH PRIVATE INVESTORS ApS: Financial statements 2020
CVR: 26284384
NORDIC BIOTECH PRIVATE INVESTORS ApS (CVR 26284384) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -15,938 and a net result of DKK -54,970 compared with DKK 261,595 the year before. Equity amounted to DKK 2,678,923. The solvency ratio was 99.6%.
- Gross Profit
- -15,938 kr.
- Profit/Loss
- -54,970 kr.
- Equity
- 2,678,923 kr.
- Total Assets
- 2,690,174 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -16 t. | -55 t. | 2.7 mio. | - |
| 2019 | - | -29 t. | 262 t. | 2.7 mio. | - |
| 2018 | - | -24 t. | -10.6 mio. | 2.5 mio. | 0 |
| 2017 | - | 47.5 mio. | 2.9 mio. | 13.1 mio. | - |
| 2016 | - | -21 t. | -24.7 mio. | 56.8 mio. | - |
How creditworthy is NORDIC BIOTECH PRIVATE INVESTORS ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
NORDIC BIOTECH PRIVATE INVESTORS ApS has published its annual report for 2019. Gross profit came to DKK -29,250, and the net result was DKK 261,595.
About NORDIC BIOTECH PRIVATE INVESTORS ApS
NORDIC BIOTECH PRIVATE INVESTORS ApS was a Danish company of the type Anpartsselskab based in Hellerup, founded in 2001. The company was registered under the industry Ikke-finansielle holdingselskaber. The management consists of Jakob Mosegaard Larsen. The company's owners include Thue Walter Schwartz, Peter Moldt and Dorte Kloppenborg Skrumsager. In 2025, the company reported a gross profit of DKK -432,293 and a net result of DKK -571,396 compared with DKK 2,080,087 the year before. Equity amounted to DKK 2,975,449.